Literature DB >> 18989667

Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Shinro Matsuo1, Kenichi Nakajima, Koichi Okuda, Masaya Kawano, Takehiro Ishikawa, Tetsuo Hosoya, Junichi Taki, Seigo Kinuya.   

Abstract

BACKGROUND: Although the heart-to-mediastinum (H/M) ratio in a planar image has been used for practical quantification in (123)I-metaiodobenzylguanidine (MIBG) imaging, standardization of the parameter is not yet established. We hypothesized that the value of the H/M ratio could be standardized to the various camera-collimator combinations. METHODS AND
RESULTS: Standard phantoms consisting of the heart and mediastinum were made. A low-energy high-resolution (LEHR) collimator and a medium-energy (ME) collimator were used. We examined multi-window correction methods with (123)I- dual-window (IDW) acquisition, and planar images were obtained with IDW correction and the LEHR collimator. The images were obtained using the following gamma camera systems: GCA 9300A (Toshiba, Tokyo), E.CAM Signature (Toshiba/Siemens, Tokyo) and Varicam (GE, Tokyo). Cardiac phantom studies demonstrated that contamination of the H/M count ratio was greater with the LEHR collimator and least with the ME collimator. The corrected H/M ratio with the LEHR collimator was similar to that with ME collimators. The uncorrected H/M ratio with the ME collimator was linearly related to the H/M ratio with IDW correction with the LEHR collimator. The relationship between the uncorrected H/M ratios determined with the LEHR (E.CAM) and the ME collimators was y = 0.56x + 0.49, where y = H/M ratio with the E.CAM and x = H/M ratio with the ME collimator. The average normal values for the low-energy collimator (n=18) were 2.2+/-0.2 (initial H/M ratio) and 2.42+/-0.2 (delayed H/M ratio), and for the low/medium-energy (LME) collimator (n=14) were 2.63+/-0.25 (initial H/M ratio) and 2.87+/-0.19 (delayed H/M ratio). H/M ratios in previous clinical studies using LEHR collimators are comparable to those with ME collimators.
CONCLUSION: The IDW-corrected H/M ratios determined with the LEHR collimator were similar to those determined with the ME collimator. This finding could make it possible to standardize the H/M ratio in planar imaging among various collimators in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989667     DOI: 10.1007/s00259-008-0971-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  25 in total

1.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.

Authors:  J Yamazaki; H Muto; T Kabano; S Yamashina; S Nanjo; A Inoue
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

2.  Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging.

Authors:  S Matsuo; Y Nakamura; T Matsui; T Matsumoto; M Kinoshita
Journal:  Ann Nucl Med       Date:  2001-08       Impact factor: 2.668

3.  Cardiac sympathetic dysfunction in an athlete's heart detected by 123I-metaiodobenzylguanidine scintigraphy.

Authors:  S Matsuo; Y Nakamura; M Takahashi; T Matsui; J Kusukawa; S Yoshida; H Hamamoto; M Kinoshita
Journal:  Jpn Circ J       Date:  2001-05

4.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

5.  Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.

Authors:  Tomoaki Nakata; Takeru Wakabayashi; Michifumi Kyuma; Toru Takahashi; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-25       Impact factor: 9.236

6.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.

Authors:  Kenichi Nakajima; Kosuke Matsubara; Takehiro Ishikawa; Nobutoku Motomura; Ryo Maeda; Nasima Akhter; Koichi Okuda; Junichi Taki; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

7.  Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.

Authors:  Hitoshi Nagamatsu; Mitsuru Momose; Hideki Kobayashi; Kiyoko Kusakabe; Hiroshi Kasanuki
Journal:  Ann Nucl Med       Date:  2007-11-26       Impact factor: 2.668

8.  Prognostic value of iodine-123 metaiodobenzylguanidine imaging in patients with heart failure.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Tetsuya Matsumoto; Ichiro Nakae; Kiyoshi Murata; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2003

9.  Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

Review 10.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 10.057

View more
  13 in total

1.  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.

Authors:  Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Mitsuhiro Yoshita; Junichi Taki; Masahito Yamada; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

2.  Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure.

Authors:  Shu Kasama; Takuji Toyama; Ryuichi Funada; Noriaki Takama; Norimichi Koitabashi; Shuichi Ichikawa; Yasuyuki Suzuki; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-30       Impact factor: 9.236

3.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

4.  An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators.

Authors:  Yusuke Inoue; Yutaka Abe; Yuji Asano; Kei Kikuchi; Keiji Matsunaga; Takahiro Iizuka; Kazutoshi Nishiyama
Journal:  J Nucl Cardiol       Date:  2014-04-09       Impact factor: 5.952

5.  Clinical use of nuclear cardiology in the assessment of heart failure.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya
Journal:  World J Cardiol       Date:  2010-10-26

6.  Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.

Authors:  Teresa Pellegrino; Mario Petretta; Serena De Luca; Stefania Paolillo; Antonio Boemio; Raffaella Carotenuto; Maria Piera Petretta; Carmine di Nuzzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

7.  Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.

Authors:  Koichi Okuda; Kenichi Nakajima; Tetsuo Hosoya; Takehiro Ishikawa; Takahiro Konishi; Kosuke Matsubara; Shinro Matsuo; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2010-11-23       Impact factor: 5.952

8.  Influence of ROI definition on the heart-to-mediastinum ratio in planar 123I-MIBG imaging.

Authors:  Christiane Klene; Christiane Jungen; Koichi Okuda; Yuske Kobayashi; Annabelle Helberg; Janos Mester; Christian Meyer; Kenichi Nakajima
Journal:  J Nucl Cardiol       Date:  2016-11-01       Impact factor: 5.952

9.  (123)I-MIBG Scintigraphy as a Powerful Tool to Plan an Implantable Cardioverter Defibrillator and to Assess Cardiac Resynchronization Therapy in Heart Failure Patients.

Authors:  Antonella Stefanelli; Giorgio Treglia; Alessandro Giordano
Journal:  Int J Mol Imaging       Date:  2012-09-26

Review 10.  Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function.

Authors:  Kenichi Nakajima
Journal:  Ann Nucl Med       Date:  2010-01-29       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.